Advertisement

AIDS and Behavior

, Volume 14, Issue 6, pp 1347–1352 | Cite as

Using Mobile Phones to Improve Clinic Attendance Amongst an Antiretroviral Treatment Cohort in Rural Uganda: A Cross-sectional and Prospective Study

  • Setor Kunutsor
  • John Walley
  • Elly Katabira
  • Simon Muchuro
  • Hudson Balidawa
  • Elizabeth Namagala
  • Eric Ikoona
Original Paper

Abstract

We aimed to assess the patterns and dynamics of mobile phone usage amongst an antiretroviral treatment (ART) cohort in rural Uganda and ascertain its feasibility for improving clinic attendance. A cross-sectional study of clients on ART exploring their access to mobile phones and patterns of use was employed. Clinic attendances for antiretroviral drug refills were then monitored prospectively over 28 weeks in 176 patients identified in the cross-sectional survey who had access to mobile phones and had given consent to be contacted. Patients were contacted via voice calls or text messages to remind them about their missed clinic appointments. Of the 276 patients surveyed, 177 (64%) had access to mobile phones with all but one were willing to be contacted for missed visits reminders. Of the 560 total scheduled clinic appointments, 62 (11%) were missed visits. In 79% of episodes in which visits were missed, patients presented for treatment within a mean duration of 2.2 days (SD = 1.2 days) after mobile phone recall. Access to mobile phones was high in this setting. Privacy and confidentiality issues were not considered deterrents. Mobile phones have a potential for use in resource-constrained settings to substantially improve the clinical management of HIV/AIDS.

Keywords

Adherence Attendance Anti-retroviral therapy Mobile phones HIV AIDS 

Notes

Acknowledgments

We acknowledge the support of the Ugandan National AIDS Control Programme in facilitating this study. The study team also acknowledges the contributions of clients on ART at the various sites. We particularly thank the Research Assistant, Nicholas Ssendege and the adherence workers namely Solomy Kataabu, Josephine Mirembe, Isaac Buzaka and Loyce Babirye for their immense contribution during data collection. We also thank the management and health workers of the health facilities where these surveys were conducted. The study was conducted by the Department for International Development (DFID) funded Communicable Disease Research Programme (COMDIS), Nuffield Centre for International Health and Development, Leeds University, United Kingdom.

References

  1. 1.
    UNAIDS 2008 Report on the global AIDS epidemic. 2008. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp. Accessed 02 June 2010.
  2. 2.
    Detels R, Munoz A, McFarlane G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. JAMA. 1998;280:1497–503.CrossRefPubMedGoogle Scholar
  3. 3.
    Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.PubMedGoogle Scholar
  4. 4.
    Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001;33:1417–23.CrossRefPubMedGoogle Scholar
  5. 5.
    Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Turner BJ. Adherence to antiretroviral therapy by HIV-infected patients. J Infect Dis. 2002;185(2):143–51.CrossRefGoogle Scholar
  7. 7.
    Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and class-specific antiretroviral resistance. AIDS. 2009;23(9):1035–46.CrossRefPubMedGoogle Scholar
  8. 8.
    Parienti J-J, Das-Douglas M, Massari V, et al. Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE. 2008;3(7):e2783.CrossRefPubMedGoogle Scholar
  9. 9.
    Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1990;131:81–7.Google Scholar
  10. 10.
    Rastegar DA, Fingerhood MI, Jasinki DR. Highly active antiretroviral therapy outcomes in a primary care clinic. AIDS Care. 2003;15:231–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Park WB, Choe PG, Kim SH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patient. J Intern Med. 2007;261:268–75.CrossRefPubMedGoogle Scholar
  12. 12.
    Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5:1469–76.PubMedGoogle Scholar
  13. 13.
    Wood PR, Casey R, Kolski GB, McCormick MC. Compliance with oral theophylline therapy in asthmatic children. Ann Allergy. 1985;54:400–4.PubMedGoogle Scholar
  14. 14.
    Giordano TP, Gifford AL, Clinton White A, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44:1493–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Laurent C, Diakhate N, Fatou Ngom Gueye N, et al. The Senegalese government’s highly active antiretroviral therapy initiative: an 18-month follow-up study. AIDS. 2002;16(10):1363–70.CrossRefPubMedGoogle Scholar
  16. 16.
    Orrell C, Bangsberg D, Badri M, Wood R. Adherence is not a barrier to delivery of HIV antiretroviral therapy in resource-poor countries. AIDS. 2003;17:1369–75.CrossRefPubMedGoogle Scholar
  17. 17.
    Kunutsor S, Evans M, Thoulass J, et al. Ascertaining baseline levels of antiretroviral therapy adherence in Uganda: a multi-method approach. J Acquir Immune Defic Syndr. 2010, June 07. (Epub ahead of print). http://journals.lww.com/jaids/Abstract/publishahead/Ascertaining_Baseline_Levels_of_Antiretroviral.98990.aspx.
  18. 18.
    World Health Organization. WHA58.28 e-Health. Geneva: WHO; 2005.Google Scholar
  19. 19.
    World Health Organization. Strategy 2004–2007. E-health for health care delivery. Geneva: WHO; 2004.Google Scholar
  20. 20.
    Morris K. Mobile Phones connecting efforts to tackle infectious disease, Newsdesk, The Lancet. May 2009;9. Available at: http:\\www.thelancet.com/infections. Accessed 28 October 2009.
  21. 21.
    Compendium of ICT applications on electronic government: volume 1. Mobile applications on health and learning. Department of Economic and Social Affairs, Division for Public Administration and Development Management. United Nations. 2007. Available at: http://www.unapcict.org/ecohub/resources/compendium-of-ict-applications-on-electronic. Accessed 03 March 2010.
  22. 22.
    Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77.PubMedGoogle Scholar
  23. 23.
    International Telecommunication Union. Measuring the information society—The ICT Development Index 2009. Available at: http://www.itu.int/net/pressoffice/backgrounders/general/pdf/5.pdf. Accessed 02 June 2010.
  24. 24.
    Shet A, Arumugam K, Rodrigues R, et al. Designing a mobile phone-based intervention to promote adherence to antiretroviral therapy in South India. AIDS Behav. 2010 Jan 7. (Epub ahead of print). Available at: http://www.springerlink.com/content/1m33549mk245u365/. Accessed 04 March 2010.
  25. 25.
    Ronald A, Plummer F, Ngugi E, et al. The Nairobi STD program. An international partnership. Infect Dis Clin North Am. 1991;5:337–52.PubMedGoogle Scholar
  26. 26.
    Kaplan WA. Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Glob Health. 2006;2:9.CrossRefGoogle Scholar
  27. 27.
    Norwell N. Text messaging raises medicolegal issues. BMJ 2003;326:1148 (24 May). Available at: http://www.bmj.com/cgi/content/full/326/7399/1148-b. Accessed 03 March.Google Scholar
  28. 28.
    Downer SR, Meara JG, Da Costa AC. Use of SMS text messaging to improve outpatient attendance. Med J Aust. 2005;183:366–8.PubMedGoogle Scholar
  29. 29.
    Collier AC, Ribaudo H, Mukherjee AL, Feinberg J, Fischl MA, Chesney M. A randomized study of serial telephone call support to increase adherence and thereby improve virologic outcome in persons initiating antiretroviral therapy. J Infect Dis. 2005;192:1398–1398.CrossRefPubMedGoogle Scholar
  30. 30.
    Hamilton W. General practice non-attendance. A questionnaire survey. (Pub ID: N0240056126). NHS National Research Register (4) 2001. Available at: http://www.nrr.nhs.uk/ViewDocument.asp?ID=N0240056126. Accessed 03 March 2010.
  31. 31.
    Sawyer SM, Zalan A, Bond LM. Telephone reminders improve adolescent clinic attendance: a randomized controlled trial. J Paediatr Child Health. 2002;38(1):79–83.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Setor Kunutsor
    • 1
    • 4
  • John Walley
    • 1
  • Elly Katabira
    • 2
  • Simon Muchuro
    • 2
  • Hudson Balidawa
    • 3
  • Elizabeth Namagala
    • 3
  • Eric Ikoona
    • 3
  1. 1.Nuffield Centre for International Health and Development, Institute of Health SciencesLeeds UniversityLeedsUK
  2. 2.Communicable Disease Research Programme Consortium, Department of MedicineMakerere University College of Health SciencesKampalaUganda
  3. 3.Uganda National Aids Control ProgrammeKampalaUganda
  4. 4.Malaria Consortium, COMDIS MUKKampalaUganda

Personalised recommendations